Cargando…

Meropenem-Resistant Pandoraea Pneumonia in a Critically Ill Patient With COVID-19

Among patients infected with respiratory viruses, primary coinfection or secondary bacterial pneumonia is common in the severely ill. Pandoraea are multi-drug resistant gram-negative bacilli that have been newly classified in the past 20 years. We present the first reported case of Pandoraea co-infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dlewati, Mohammad M, Aung, Pyi Phyo, Park, Kyeeun, Rodriguez, Jose A, Poon, Kenneth K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666094/ https://www.ncbi.nlm.nih.gov/pubmed/34912637 http://dx.doi.org/10.7759/cureus.19498

Ejemplares similares

ODP143 Cushing Syndrome - A Potential Risk Factor For Atrial Fibrillation
por: Konindala, Navya, et al.
Publicado: (2022)

Meropenem-Resistant Achromobacter xylosoxidans, Subspecies Denitrificans Bacteremia in a Patient With Stage IV Adenocarcinoma of the Lung
por: Agassi, Andre M, et al.
Publicado: (2021)

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

ODP507 PREVALENCE OF CARDIOVASCULAR DISEASE IN PATIENTS WITH SUBCLINICAL HYPOTHYROISIM
por: Park, Kyeeun, et al.
Publicado: (2022)

Low BALF CD4 T cells count is associated with extubation failure and mortality in critically ill covid-19 pneumonia
por: Singh, Gurmeet, et al.
Publicado: (2022)

Recurrent out-of-hospital cardiac arrest related to triple-vessel coronary artery spasm: A case report
por: Xi, Qianlan, et al.
Publicado: (2023)

Early management of critically ill patients with COVID‐19
por: Gutiérrez‐Zarate, Damián, et al.
Publicado: (2020)

Prevalence of Hospital-Acquired Pneumonia Among Patients With Severe to Critical COVID-19 Pneumonia Given Tocilizumab
por: Adre, Lorenzo Abednego B, et al.
Publicado: (2023)

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
por: Dickstein, Yaakov, et al.
Publicado: (2016)

Pragmatic recommendations for intubating critically ill patients with suspected COVID‐19
por: Brown, Calvin A., et al.
Publicado: (2020)

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
por: Rosso-Fernández, Clara, et al.
Publicado: (2015)

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
por: Bitterman, Roni, et al.
Publicado: (2021)

Clinical examination, critical care ultrasonography and outcomes in the critically ill: cohort profile of the Simple Intensive Care Studies-I
por: Hiemstra, Bart, et al.
Publicado: (2017)

Prevalence of Klebsiella pneumoniae Antibiotic Resistance in Medina, Saudi Arabia, 2014-2018
por: Al-Zalabani, Abdulmohsen, et al.
Publicado: (2020)

Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study
por: Hurst, Emma A, et al.
Publicado: (2021)

Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

Evaluation of Remdesivir Utilization Pattern in Critically Ill Patients With COVID-19 in Jazan Province
por: Ayyashi, Munif, et al.
Publicado: (2023)

Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study
por: Alfaraidi, Haifa, et al.
Publicado: (2020)

Predictors of in-hospital mortality in critically ill patients with COVID-19: a large dual tertiary centre study
por: Cirillo, Chiara, et al.
Publicado: (2022)

Clinical, laboratory and imaging predictors for critical illness and mortality in patients with COVID-19: protocol for a systematic review and meta-analysis
por: Lai, Xinxing, et al.
Publicado: (2020)

Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
por: Shah, Tayyab, et al.
Publicado: (2023)

Community-Acquired, Post-COVID-19, Methicillin-Resistant Staphylococcus aureus Pneumonia and Empyema
por: McCraw, Cameron, et al.
Publicado: (2022)

Prehospital physiological parameters related illness severity scores can accurately discriminate the severe/critical state in adult patients with COVID-19
por: Li, Chen, et al.
Publicado: (2023)

Investigation on the Genetic Signatures of Antibiotic Resistance in Multi-Drug-Resistant Klebsiella Pneumoniae Isolates From National Guard Hospital, Riyadh
por: Khdary, Hassan N, et al.
Publicado: (2020)

Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis
por: Hayashida, Kei, et al.
Publicado: (2017)

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study
por: Shorr, Andrew F, et al.
Publicado: (2013)

Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial
por: Jensen, Jens-Ulrik Stæhr, et al.
Publicado: (2012)

COVID-19 Associated Illnesses From Alveoli to Glomeruli: A Case Report
por: Amin, Said, et al.
Publicado: (2022)

Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol
por: Perera, Marlon, et al.
Publicado: (2020)

Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
por: Wang, Fei, et al.
Publicado: (2023)

Community-acquired Pneumonia Secondary to Legionella pneumophila and Streptococcus pneumoniae: A Rare Co-infection
por: Beg, Moeezullah, et al.
Publicado: (2019)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
por: Hana, Caroline, et al.
Publicado: (2023)

Rising Klebsiella pneumoniae Infections and Its Expanding Drug Resistance in the Intensive Care Unit of a Tertiary Healthcare Hospital, Saudi Arabia
por: Al Bshabshe, Ali, et al.
Publicado: (2020)

Antimicrobial Therapy for Pneumonia or Fluid Overload?
por: Mbadugha, Uche J, et al.
Publicado: (2021)

Methicillin‐resistant Staphylococcus aureus and Pseudomonas aeruginosa community acquired pneumonia: Prevalence and locally derived risk factors in a single hospital system
por: Frazee, Bradley W., et al.
Publicado: (2023)

Discordance of the Urinary and Pleural Fluid Antigen Test and False Positive for Streptococcus pneumoniae in Empyema Secondary to Necrotizing Bacterial Pneumonia
por: Shumway, David O, et al.
Publicado: (2023)

Evaluation of BioFire® FilmArray® Pneumonia Panel in Bronchoalveolar Lavage Samples From Immunocompromised Patients With Suspected Pneumonia
por: Li-Geng, Tony, et al.
Publicado: (2023)

OXA-48 Dominance Meets Ceftazidime-Avibactam: A Battle Against Life-Threatening Carbapenem-Resistant Klebsiella pneumoniae Infections in the Intensive Care Unit
por: Önal, Uğur, et al.
Publicado: (2023)

Legionella: Organizing Pneumonia vs Persistent Infection
por: Khrais, Ayham, et al.
Publicado: (2022)

Epidemiological relationship between Mycoplasma pneumoniae pneumonia and recurrent wheezing episode in children: an observational study at a single hospital in Korea
por: Rhim, Jung Woo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o1c4r0ar1et0rhtdaeb8fggn1h